120 East Liberty Drive, Suite 400,
Wheaton , IL, 60187
Wheaton , IL, 60187
Summary
The fund seeks to replicate the total return performance of the benchmark index before fees and expenses by investing in companies in the United States.
The investment process starts with a list of companies in the benchmark index and the research team utilizes quantitative techniques and fundamental analysis to identify investment opportunities.
The fund employs an indexing investment approach that is designed to track the More
Webiste
Directors
Jun 8, 2023- Richard E. Erickson
- Thomas R. Kadlec
- Denise M. Keefe
- Robert F. Keith
- Niel B. Nielson
- James A. Bowen
Chief Compliance Officer
- Kristi A. Maher
Price
- $ 23.55 ( -4.37 )
-
Apr 10, 2025Last Close
- Net Assets
-
$18.6M
Feb 26, 2024
- 52-Week High/Low
- $29.6 - $23.6
- Expense Ratio
- -
Performance
YTD
0%
3 Year
-16.19%
5 Year
12.95%
Best
60.02%
2003
Worst
-56.29%
2009
Company Name |
Holding |
| Pfizer Inc | 7.65 % |
| AbbVie Inc | 7.07 % |
| Merck & Co Inc | 7.07 % |
| Johnson & Johnson | 6.57 % |
| Bristol-Myers Squibb Co | 5.94 % |
| United Therapeutics Corp | 4.64 % |
| Eli Lilly & Co | 4.36 % |
| Amgen Inc | 4.14 % |
| Vertex Pharmaceuticals Inc | 4.04 % |
| Regeneron Pharmaceuticals Inc | 3.95 % |
| More | 3.95 % |
Documents
NAV
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| FTXH | 0% | -1.5% | -3% | 2.1% | 5.4% | 9.5% | 21.4% | -9.5% | 19.4% | 0% | |
| S&P 500 | -8.3% | 23.3% | 24.2% | -19.4% | 27.3% | 16.2% | 28.9% | -6.2% | 19.4% | 9.5% |
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| q1 | 0% | 5.4% | -4.9% | -1% | -0.7% | -16.7% | 11.4% | -1.7% | 8.4% | 0% | ||||
| q2 | 0% | -5.5% | 0.3% | -0.7% | 2.2% | 17.3% | -1.6% | 6.2% | 4.6% | 0% | ||||
| q3 | 0% | 0% | -2.4% | -9.1% | -1.5% | 5% | -4.5% | 8.4% | -1.5% | -3.5% | ||||
| q4 | 0% | 0% | 4.6% | 14.1% | 5.4% | 6.7% | 14.2% | -18.2% | 7% | -6.8% |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| 2024 | 2.3% | 2.2% | 0.8% | -7.5% | 1.1% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |